相关实验视频

Updated: Jul 27, 2025

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

质瘤中的突变IDH:癌症和治疗选择中的作用

Georgios Solomou^1,2,3, Alina Finch¹, Asim Asghar¹

¹Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

|June 10, 2023

概括

异酸脱酶 (IDH) 的突变改变了细胞代谢,导致IDH突变瘤中D-2-酸酸盐 (D2-HG) 的积累. 本综述涵盖了IDH突变的后果和质瘤的向治疗方法.

科学领域:

在瘤学瘤学.
癌症新陈代谢癌症新陈代谢
生物化学生物化学

背景情况:

改变细胞代谢是癌症的标志.
异酸脱酶 (IDH) 突变在质瘤和其他癌症中很普遍.
突变的IDH产生D-2-基酸盐 (D2-HG),是一种潜在的代谢物.

研究的目的:

审查IDH突变的细胞和分子后果.
总结针对IDH突变瘤的治疗策略.
专注于IDH突变质瘤.

主要方法:

在癌症中IDH突变的文献综述.
分析IDH突变细胞中的代谢变化.
关于IDH抑制剂的临床前和临床研究摘要.

主要成果:

IDH突变重新编程TCA循环,导致D2-HG的积累.
较高的D2-HG水平与IDH突变瘤有关.
向疗法旨在抑制突变的IDH活性.

结论:

IDH突变显著影响癌细胞代谢和表观遗传学.
针对突变IDH的抑制剂代表了质瘤的有希望的治疗途径.
需要进一步的研究,以充分阐明D2-HG的作用和优化治疗策略.

关键词:

癌症的代谢癌症的代谢质瘤是一种质瘤.氧氨酸酸的含量是多少异酸盐脱基酶是什么在合成代谢物上.

更多相关视频

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...